The Gaining Momentum of BCMA-Directed Therapies for Relapsed/Refractory Multiple Myeloma
Despite significant developments in the treatment of multiple myeloma (MM) over the past decade, many patients still experience relapse due to resistance to antimyeloma therapies. Particularly in the relapsed/refractory setting, recent treatment advances have resulted in significantly improved progn...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2023-10-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/hbT.OH.2023.17.123 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|